• Zhejiang Taimei Medical Technology repurchased 52,400 H shares on July 15, 2026 for treasury, per an HKEX next-day disclosure return.
• Buyback price range HKD 6 to HKD 6.26; aggregate consideration HKD 323,208.
• Total repurchased shares: 52,400; total cancelled shares: 0.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhejiang Taimei Medical Technology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260715-12245381), on July 15, 2026, and is solely responsible for the information contained therein.